Sugar end-capped poly-d,l-lactides as excipients in oral sustained release tablets

AAPS PharmSciTech

Volumn 10, Issue 2, 2009, Pages 566-573

  Vuorinen, Sirpa ^a   Heinämäki, Jyrki ^a   Antikainen, Osmo ^a   Lahcini, Mohammed ^b   Repo, Timo ^a   Yliruusi, Jouko ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b CADI AYYAD UNIVERSITY   (Morocco)

Author keywords

Direct compression; Matrix tablets; Poly D,L lactide; Release kinetics; Sustained release; Theophylline

Indexed keywords

EXCIPIENT; POLY DEXTRO LACTIDE DERIVATIVE; POLYMER; SUGAR; THEOPHYLLINE; UNCLASSIFIED DRUG; LACTIC ACID; METHYLGLUCOSIDE; POLYLACTIC ACID;

ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; ENCAPSULATION; IN VITRO STUDY; MATRIX TABLET; MOLECULAR WEIGHT; POLYMERIZATION; SCANNING ELECTRON MICROSCOPY; SUSTAINED RELEASE PREPARATION; TABLET COMPRESSION; CHEMISTRY; DELAYED RELEASE FORMULATION; DIFFERENTIAL SCANNING CALORIMETRY; INFRARED SPECTROSCOPY; ORAL DRUG ADMINISTRATION; PHARMACEUTICS; POWDER; SOLUBILITY; TABLET;

ADMINISTRATION, ORAL; CALORIMETRY, DIFFERENTIAL SCANNING; DELAYED-ACTION PREPARATIONS; EXCIPIENTS; LACTIC ACID; METHYLGLUCOSIDES; POLYMERS; POWDERS; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TABLETS; TECHNOLOGY, PHARMACEUTICAL;

EID: 67549132991     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-009-9247-9     Document Type: Article

References (23)

1. Ishikawa T, Watanabe Y, Takayama K, Endo H, Matsumoto M. Effect of hydroxypropylmethylcellulose (HPMC) on the release profiles and bioavailability of a poorly water-soluble drug from tablets prepared using macrogol and HPMC. Int J Pharm 2000;202:173-8.
2. Williams RO III, Sykora MA, Mahaguna V. Method to recover a lipophilic drug from hydroxypropyl methylcellulose matrix tablets. AAPS PharmSciTech 2001;2(2):8. article.
3. Al-Taani BM, Tashtoush BM. Effect of microenvironment pH of swellable and erodible buffered matrices on the release characteristics of diclofenac sodium. AAPS PharmSciTech 2003;4(3):43. article.
4. Brouillet F, Bataille B, Cartilier L. High-amylose sodium carboxymethyl starch matrices for oral, sustained drug-release: Formulation aspects and in vitro drug-release evaluation. Int J Pharm 2008;356:52-60.
5. Stridsberg KM, Ryner M, Albertsson A-C. Controlled ring-opening polymerization: Polymers with designed macromolecular architecture. Adv Polym Sci 2002;157:42.
6. Södergård A, Stolt M. Properties of lactic acid based polymers and their correlation with composition. Prog Polym Sci 2002;27:1123-63.
7. Brannon-Peppas L, Vert M. Polylactic and polyglycolic acids as drug delivery carriers. In: Wise DL, editor. Handbook of pharmaceutical controlled release technology. New York: Marcel Dekker; 2000. p. 99-130.
8. Bodmeier R, Chen H. Evaluation of biodegradable poly(lactide) pellets prepared by direct compression. J Pharm Sci 1998;78:819-22.
9. Murakami H, Kobayashi M, Takeuchi H, Kawashima Y. Utilization of poly(dl -lactide-co-glycolide) nanoparticles for preparation of mini-depot tablets by direct compression. J Controlled Release 2000;67:29-36.
10. Takahashi M, Onishi H, Machida Y. Development of implant tablet for a week-long sustained release. J Controlled Release 2004;100:63-4.
11. Mank R, Kala M, Richter M. Darstellung peroralel retardarzneiformen auf der basis von biologisch abbaubaren polymeren. 2. Mitteilung: darstellung von matrixtabletten auf der basis von polymilchsäure. Pharmazie 1989;44:328-30.
12. Moll F, Köller G. Biodegradable tablets having a matrix of low molecular weight poly- l -lactic acid and poly- dl -lactic acid. Arch Pharm 1990;323:887-8.
13. Steendam R, Lerk CF. Poly(dl -lactic acid) as direct compression excipient in controlled release tablets. Part I. Compaction behaviour and release characteristics of poly(dl -lactic acid) matrix tablets. Int J Pharm 1998;175:33-46.
14. Steendam R, van Steenbergen MJ, Hennink WE, Frijlink HW, Lerk CF. Effect of molecular weight and glass transition on relaxation and release behaviour of poly(dl -lactic acid) tablets. J Controlled Release 2001;70:71-82.
15. Mank R, Kala M, Richter M. Darstellung peroralel retardarzneiformen auf der basis von biologisch abbaubaren polymeren. 1. Mitteilung: darstellung und charakterisierung von polymilchsäure. Pharmazie 1989;44:276-9.
16. Omelczuk MO, McGinity JW. The influence of polymer glass transition and molecular weight on drug release from tablets containing poly(dl -lactic acid). Pharm Res 1992;9(1):26-32.
17. Omelczuk MO, McGinity JW. A comparative investigation of the compaction and dissolution properties of tablets containing poly(d, l -lactic acid) as a binder and retardant polymer. STP Pharm Sci 1995;5(3):181-6.
18. Thomas IM. The preparation of alkoxides and triethylsilanolates of Ti, Zr, V, Nb, Ta and Sn from the dialkylamides. Can J Chem 1961;39:1386-9.
19. Kalmi M, Lahcini M, Castro P, Lehtonen O, Belfkira A, Leskelä M, Repo T. Tetrakis Sn(IV) alkoxides as novel initiators for living ring-opening polymerization of lactides. J Polym Sci 2004;42:1901-11.
20. Garlotta D. A literature review of poly(lactic acid). J Polym Environ 2001;9:63-84.
21. Kister G, Cassanas G, Vert M. Effect of morphology, conformation and configuration on the IR and Raman spectra of various poly(lactic acid)s. Polym 1998;39:267-73.
22. Agarwal M, Koelling KW, Chalmers JJ. Characterization of the degradation of polylactic acid polymer in a solid substrate environment. Biotechnol Prog 1998;14:517-26.
23. Streubel A, Siepmann J, Dashevsky A, Bodmeier R. pH-independent release of a weakly basic drug from water-insoluble and -soluble matrix tablets. J Controlled Release 2000;67:101-10.